AI Assessment of Low-Gradient Aortic Stenosis Severity Based on Echocardiography
Recruiting
Observational Study
Low-gradient Aortic Stenosis
Aortic Stenosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 300 (estimated)
- Sponsor
- National Institute of Cardiology, Warsaw, Poland · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to evaluate the effectiveness of an artificial intelligence (AI) model developed by the investigators for identifying severe low-gradient aortic valve stenosis. Accurate assessment of stenosis severity is crucial for proper qualification for surgical treatment. It is expected that the use of AI will improve diagnostic accuracy and thereby support better clinical outcom…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Clinical suspicion of significant low-gradient aortic stenosis
* Echocardiographic examination performed for clinical indications
* Ability to provide informed consent
Exclusion Criteria:
* Previous aortic valve intervention (surgical or transcatheter)
* Ina…
Contacts